Status:

UNKNOWN

Validity of PEEK PSI Containing Autogenous Bone Graft for Maxillary Reconstruction Following Lesion Enucleation

Lead Sponsor:

Cairo University

Conditions:

Maxillary Cyst

Eligibility:

All Genders

15-60 years

Phase:

NA

Brief Summary

Surgical ablation of large maxillary cysts usually results in considerable hard and soft tissue deficits that ultimately affect the final esthetic and functional outcomes. Reconstruction of such defec...

Eligibility Criteria

Inclusion

  • Age of patients from 15 to 60 years old.
  • Patients with unilateral maxillary lesion encroaching maxillary sinus.
  • Dentulous or edentulous patients.
  • Patients should be free from any systemic disease that may affect normal healing of bone and predictable outcome.

Exclusion

  • Patients with systemic diseases as history of radiation therapy or chemotherapy, hematological disorders, neuromotor disorders and autoimmune diseases (may affect normal healing).
  • Patients with bilateral maxillary lesions.
  • Children under 15 years old.

Key Trial Info

Start Date :

January 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2018

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT03265795

Start Date

January 1 2018

End Date

July 1 2018

Last Update

August 30 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Validity of PEEK PSI Containing Autogenous Bone Graft for Maxillary Reconstruction Following Lesion Enucleation | DecenTrialz